RecruitingEarly Phase 1NCT03810651

Pencil Beam Scanning in Patients With Renal Tumors

Pilot Study of Pencil Beam Scanning Proton Beam Radiation Therapy in Patients With Renal Tumors


Sponsor

Children's Hospital of Philadelphia

Enrollment

28 participants

Start Date

Dec 26, 2017

Study Type

INTERVENTIONAL

Conditions

Summary

This is a pilot study to assess acute toxicity in patients receiving flank irradiation using proton therapy for renal tumors.


Eligibility

Min Age: 0 YearsMax Age: 30 Years

Inclusion Criteria7

  • Less than 30 years of age
  • Diagnosis
  • a. Any patient with Wilms tumor or clear cell sarcoma of the kidney who would require radiation therapy as standard of care including
  • Any patient with favorable histology (FH), stage III disease
  • Any patient with focal or diffuse anaplasia
  • Any patient with CCSK
  • The patient is a candidate for external beam radiotherapy based on standard of care for treatment of Wilms tumor or CCSK

Exclusion Criteria3

  • Prior radiotherapy to the region of the study cancer
  • Chemotherapy administered for diagnosis of Wilms tumor or CCSK
  • Pregnant or breastfeeding

Interventions

OTHERProton beam radiation using pencil beam scanning

Proton beam radiation using pencil beam scanning, characterized by Bragg peak dose deposition and high conformality of dose to target regions


Locations(1)

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03810651


Related Trials